Retracted and republished: A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

…, R Tadros, A Bhonsale, M Bourfiss… - European heart …, 2019 - academic.oup.com
… 1 , Mimount Bourfiss … Lie 6,7 , Ardan M. Saguner … O’Mahony C, Jichi F, Pavlou M,
Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ …

Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration

…, R Tadros, A Bhonsale, M Bourfiss… - Circulation …, 2021 - Am Heart Assoc
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with
ventricular arrhythmias (VA) and sudden cardiac death (SCD). A model was recently …

A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy

…, R Tadros, A Bhonsale, M Bourfiss… - European heart …, 2022 - academic.oup.com
Aims Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC) is characterized
by ventricular arrhythmias (VAs) and sudden cardiac death (SCD). We aimed to develop a …

Druggable proteins influencing cardiac structure and function: Implications for heart failure therapies and cancer cardiotoxicity

AF Schmidt, M Bourfiss, A Alasiri, E Puyol-Anton… - Science …, 2023 - science.org
Dysfunction of either the right or left ventricle can lead to heart failure (HF) and subsequent
morbidity and mortality. We performed a genome-wide association study (GWAS) of 16 …

Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: clinical performance and simplified practical implementation

…, M Bourfiss, M Aliyari Ghasabeh… - EP …, 2020 - academic.oup.com
Aims Arrhythmogenic right ventricular cardiomyopathy (ARVC) is diagnosed by a complex
set of clinical tests as per 2010 Task Force Criteria (TFC). Avoiding misdiagnosis is crucial to …

[HTML][HTML] Feature tracking CMR reveals abnormal strain in preclinical arrhythmogenic right ventricular dysplasia/cardiomyopathy: a multisoftware feasibility and clinical …

M Bourfiss, DM Vigneault, MA Ghasebeh… - Journal of …, 2016 - Elsevier
Background Regional right ventricular (RV) dysfunction is the hallmark of Arrhythmogenic
Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C), but is currently only qualitatively …

Prevalence and disease expression of pathogenic and likely pathogenic variants associated with inherited cardiomyopathies in the general population

M Bourfiss, M van Vugt, AI Alasiri… - Circulation: Genomic …, 2022 - Am Heart Assoc
… ) between 100 and 110 mL/m −2 for men or between 90 and 100 mL/m −2 for women, … had
an RVEDVi larger than 110 mL/m −2 for men or 100 mL/m −2 for women, meeting the major …

Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study

…, S Costa, M Bourfiss, M Pérez-Hernández… - European heart …, 2022 - academic.oup.com
Aims Exercise increases arrhythmia risk and cardiomyopathy progression in arrhythmogenic
right ventricular cardiomyopathy (ARVC) patients, but the mechanisms remain unknown. …

Prognostic value of strain by feature-tracking cardiac magnetic resonance in arrhythmogenic right ventricular cardiomyopathy

M Bourfiss, NHJ Prakken, CA James… - European Heart …, 2023 - academic.oup.com
Aims Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by ventricular
dysfunction and ventricular arrhythmias (VA). Adequate arrhythmic risk assessment is …

A head-to-head comparison of speckle tracking echocardiography and feature tracking cardiovascular magnetic resonance imaging in right ventricular deformation

K Taha, M Bourfiss, ASJM Te Riele… - European Heart …, 2021 - academic.oup.com
Aims Speckle tracking echocardiography (STE) and feature tracking cardiovascular magnetic
resonance imaging (FT-CMR) are advanced imaging techniques which are both used for …